Citryll
Netherlands - OssBiotechnology
Focus: Citryll is a Netherlands-based biotech company focused on novel treatments targeting neutrophil extracellular trap (NET) formation, with applications in dermatology and immunology.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Citryll?
AI assessmentCitryll is a speculative early-stage bet suited for risk-tolerant professionals seeking foundational impact in a focused immunology platform, but limited hiring and pipeline maturity constrain near-term career acceleration.
Why Work Here
- Opportunity to work on a differentiated mechanism (NET formation) with only 4 active trials and early-stage programs offering clear career progression visibility
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
1 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
[89Zr]Zr-CIT
RAClinical Trials (1)
NCT07147959PET-Based Imaging of Radiolabeled CIT-013
Phase 2Help build intelligence for Citryll
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.